Rate of serious infections in Behçet's disease patients receiving biologic therapies: a prospective observational study

Clin Rheumatol. 2013 Oct;32(10):1547-8. doi: 10.1007/s10067-013-2290-7. Epub 2013 May 26.
No abstract available

Publication types

  • Observational Study

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Behcet Syndrome / complications*
  • Behcet Syndrome / therapy*
  • Biological Products / adverse effects*
  • Biological Therapy / adverse effects*
  • Female
  • Humans
  • Infections / complications*
  • Infections / etiology
  • Inflammation
  • Infliximab
  • Male
  • Middle Aged
  • Prospective Studies
  • Research Design
  • Risk
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • Infliximab
  • Adalimumab